Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: The multiparametric approach is not convincing.

Date publication

avril 2017

Journal

Seminars in oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ROYER Bernard

Tous les auteurs :
Etienne-Grimaldi MC, Le Guellec CB, Boyer JC, Chatelut E, Evrard A, Loriot MA, Paci A, Royer B, Thomas F, Ciccolini J

Lien Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/28923215

Mots clés

Dihydropyrimidine Dehydrogenase Deficiency, Dihydrouracil Dehydrogenase (NADP), Drug-Related Side Effects and Adverse Reactions, Fluorouracil, Humans

Référence

Semin. Oncol.. 2017 Apr;44(2):159-160